ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important June 25 Deadline in Securities Class Action
- Written by Newsfile
New York, New York--(Newsfile Corp. - June 15, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Akero Therapeutics, Inc. (NASDAQ: AKRO) between September 13, 2022 and October 9, 2023, both dates inclusive (the "Class Period"), of the important June 25, 2024 lead plaintiff deadline.
SO WHAT: If...